![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
chevron_left Bispecific Antibodies to Treat Multiple Myeloma: An Educational Guide
Introduction
Understanding Bispecific Antibodies
Eligibility and Administration
Treatment Course
Side Effects of Bispecific Antibodies
Side Effect Management and Support
FDA Approved Bispecific Antibodies
Bispecific Antibodies in Clinical Trials
Treatment Strategies with Bispecific Antibodies
Caregiver Role in Bispecific Antibody Therapy
Financial Resources for Bispecific Antibody Therapy
Future Considerations of Bispecific Antibody Therapy
Share Your Experience
Questions to Ask Your Doctor about Bispecific Antibody Therapy
Additional Resources
chevron_left Bispecific Antibodies to Treat Multiple Myeloma: An Educational Guide
Introduction
Understanding Bispecific Antibodies
Eligibility and Administration
Treatment Course
Side Effects of Bispecific Antibodies
Side Effect Management and Support
FDA Approved Bispecific Antibodies
Bispecific Antibodies in Clinical Trials
Treatment Strategies with Bispecific Antibodies
Caregiver Role in Bispecific Antibody Therapy
Financial Resources for Bispecific Antibody Therapy
Future Considerations of Bispecific Antibody Therapy
Share Your Experience
Questions to Ask Your Doctor about Bispecific Antibody Therapy
Additional Resources
Infection Risk (3/3)
Last updated on: 8/1/2024
Infection Risk - Additional Resources
Infection risk should be taken seriously, and patients and their care partners should be educated on how these infections occur and what can be done to prevent them, such as masking, hand washing, vaccinations, etc.
Review the resources to further your education on this subject:
- Infection Prevention
- News Article: Risk of Infections Using Bispecific Antibodies in Multiple Myeloma (2024)
- HealthTree University Video: What Patients Should Know About Bispecific Antibody Therapy and the Risk for Infection (2023)